Showing posts with label Hormone Replacement. Show all posts
Showing posts with label Hormone Replacement. Show all posts

Wednesday, March 18, 2009

Hormone Might Help Restore Female Fertility

(HealthDay News) -- A hormone called kisspeptin may offer a new treatment for infertility, according to British researchers who found that the hormone can activate the release of sex hormones that control the menstrual cycle.

The study included 10 women who were not menstruating and were infertile due to a hormone imbalance. The researchers injected the participants with either kisspeptin or saline and then measured levels of two sex hormones -- luteinising hormone (LH) and follicle stimulating hormone (FSH) -- essential for ovulation and fertility.

The women who received kisspeptin had a 48-fold increase in LH and a 16-fold increase in FSH, compared to those who received the saline. The study is the first to show that kisspeptin can stimulate production of sex hormones in infertile women, according to the study's authors.

The findings were presented at a Society for Endocrinology meeting in the United Kingdom.

"This research shows that kisspeptin offers huge promise as a treatment for infertility," study author Dr. Waljit Dhillo, of Imperial College London, said in a society news release.

"From our previous results, we know that kisspeptin can stimulate release of reproductive hormones in healthy women. We have now extended this research to show that kisspeptin treatment has the same effect in women with infertility. In fact, our current data show that kisspeptin causes a greater increase in luteinising hormone production in non-menstruating women than in fertile women in the previous study," Dhillo said.

"This is a very exciting result and suggests that kisspeptin treatment could restore reproductive function in women with low sex hormone levels. Our future research will focus on determining the best protocol for repeated kisspeptin administration with the hope of developing a new therapy for infertility," he added.

According to the researchers, kisspeptin is an important regulator of reproductive function. Animals that lack kisspeptin function don't go through puberty and remain sexually immature.

More information
The U.S. National Women's Health Information Center has more about infertility.

Friday, August 22, 2008

HRT After Menopause Reduces Symptoms

(HealthDay News) -- Hormone replacement therapy, even when it's started many years after menopause, can reduce some of the quality-of-life problems caused by menopause, such as sleep problems and hot flashes.

Australian researchers report that women who started hormone replacement therapy (HRT) after menopause and took it for an average of one year had significant improvements in sexual functioning, and fewer sleep problems, hot flashes and sweating than did women taking a placebo.

"The greatest benefits and least risk from HRT are seen in the 99 percent of women who commence HRT for symptom relief near menopause. [This] trial studied much older women who started HRT on average 13 to 14 years after menopause when they had fewer symptoms. Even in this group, improved quality of life was seen in many [taking HRT]," said study author Dr. Alastair MacLennan, head of obstetrics and gynecology at the Women's and Children's Hospital at the University of Adelaide in Australia.

Results of the study were published in the Aug. 22 issue of the British Medical Journal.

Hormone replacement therapy has been under major scrutiny since the Women's Health Initiative (WHI) study was stopped in 2002 because of increases in blood clots, heart disease, stroke and breast cancer risk in women initiating HRT long after menopause. MacLennan's study (dubbed the WISDOM study), which began in 1999 and was originally intended to follow women for up to 10 years on HRT, was also stopped after the WHI findings were released due to concerns that the risks of HRT might outweigh the benefits.

Even though the trial was stopped early, MacLennan and his colleagues had one-year follow-up data for 2,130 women between the ages of 50 and 69. The average age in this study was 63.8.

The women had been randomly assigned to receive either a combination hormone replacement therapy or a placebo. At the time of follow-up, 1,043 were on HRT and 1,087 were on placebo.

Women taking HRT had improvements in many quality-of-life symptoms. For example, hot flashes occurred in 30 percent of the women in the HRT group before starting the hormones, but in just 14 percent at the one year follow-up. In comparison, 29 percent of women taking placebo had hot flashes at the start of the study, while 25 percent were still experiencing them at the follow-up. Improvements were also seen in night sweats, insomnia and vaginal dryness.

Women in the HRT group were, however, more likely to report breast tenderness and vaginal discharge.

No significant differences were seen in reports of depression between the two groups.

The study authors wrote that if women are considering taking HRT many years after menopause, they needed to balance the benefits of hormone therapy against the possible risks when started after menopause, which include heart disease, blood clots and an increased risk of breast cancer.

"I think this is an important study, because since WHI, many have lost sight of the significant benefits of hormone therapy," said Dr. Steven R. Goldstein, an obstetrician and gynecologist at New York University Langone Medical Center. "This study reinforces the notion that for women with these symptoms, HRT can improve your quality of life. And, the worse your symptoms, the more they'll improve."

Plus, both MacLennan and Goldstein pointed out that most women would initiate HRT near menopause, when these symptoms tend to be most severe, and at that time, potential risks are much lower, and the benefits are likely greater.

"For relief of symptoms, it's OK to go on HRT, as long as you have none of the absolute contraindications, like a history of deep vein thrombosis," concluded Goldstein.

More information
To read more about hormone replacement therapy, go to the American Academy of Family Physicians.

Friday, July 11, 2008

Hormone Replacement May Raise Women's Gallbladder Risk

(HealthDay News) -- A postmenopausal woman who uses hormone replacement therapy (HRT) may boost her risk for gallbladder disease, researchers say, although the risk appears to vary depending on how she receives the hormones.

"For women who are using HRT, their risk of gallbladder disease is less if they use a patch or gel form of HRT rather than the tablet form of HRT," noted Dr. Bette Liu, a clinical epidemiologist at the University of Oxford in the United Kingdom.

"There is evidence that is developing that the patch may have less negative effects than the pill. We need to make sure that we're talking about the menopausal hormone therapy patch, not the birth control patch -- there may be less adverse effects than when taking estrogen by mouth," said Dr. Patricia J. Sulak, professor of obstetrics/gynecology at Texas A&M Health Science Center College of Medicine and an obstetrician/gynecologist with Scott & White.

According to Sulak, who was not involved in the study, hormone therapy can be taken non-orally in several ways, including gels (rubbing it on), the patch and even spraying it on.

Not only are patches and gels given at lower doses, but they bypass having to be metabolized through the liver, thus reducing any effect on the gallbladder, the authors explained. The gallbladder stores bile produced in the liver, and less estrogen collected in the bile could explain the reduced risk, the team noted.

The findings were published this week in the online edition of the British Medical Journal.

HRT is still taken by large numbers of women to relieve the symptoms of menopause -- despite evidence of various health risks, including heightened odds for breast cancer and stroke.

The risk of developing gallbladder disease also increases when a woman hits menopause, and experts have long known that HRT contributes to this risk. To date, however, no one has analyzed whether the risk varies depending on how HRT is administered. A recent study did find that the risk of blood clots was lower in women taking HRT via skin patches as opposed to pills.

In the new study, Liu and her colleagues looked at data on more than one million women who had participated in the Million Women Study in England and Scotland. The mean age of participants was 56, and they were followed for an average of six years.

Women currently using HRT were 64 percent more likely to be hospitalized for gallbladder disease, but they were only 17 percent more likely to be admitted if they were using gels or patches.

Higher doses of estrogen were associated with a higher risk than lower doses. The risk also decreased the longer the woman had been off of HRT, although there was still some risk a decade after discontinuing.

The risk seemed mainly confined to estrogen. Adding progesterone did not have a significant impact on the risk of gallbladder disease.

Estrogen implants involved a level of risk that fell between those faced by users of oral HRT and those faced by users of patches or gels.

Among women using HRT, one cholecystectomy (removal of the gallbladder) could be avoided for every 140 women using transdermal therapy rather than oral therapy over a five-year period, the team found.

According to the study, about 1.1 percent of middle-aged women in the U.K. who have never used HRT will end up having a cholecystectomy. That proportion rises to 1.3 percent among women using patches or gel and to 2 percent for women taking HRT in pill form.

"Most people will do fine with pills, but some patients who are prone to gallbladder disease or even blood clots may do better with the patch," Sulak said. "Not all women can tolerate the patch, however. They may have skin reactions, or the patch won't stay on."

More information
There's more on hormone replacement therapy at the Women's Health Initiative.

Balancing Your Hormones Without Drugs... You Can Feel Good Again

Balancing Your Hormones Without Drugs... You Can Feel Good Again

$19.95
[ learn more ]

Add to Cart

Hormone imbalance can be reversed! Look and feel better than ever, just take the time to learn about yourself and read the information contained in this just released e-book about reversing hormone imbalance. Are you ready to finally look and feel great? If so... read on... - E-Book Version.(BH)

Tuesday, October 02, 2007

Advantages and Disadvantages of Alcohol Intake on Cardiovascular Health Reviewed

News Author: Laurie Barclay, MD
CME Author: Charles Vega, MD

The latest American Heart Association guidelines caution people not to start drinking alcohol if they do not already drink alcohol, according to a review of the advantages and disadvantages of alcohol intake on cardiovascular health published in the August 23 Online First issue of the Journal of the American College of Cardiology.

"Accumulating scientific evidence indicates that light to moderate drinking done on a daily basis may significantly reduce the risks of coronary heart disease (CHD) and all-cause mortality," write James H. O'Keefe, MD, FACC, and colleagues from the Mid America Heart Institute in Kansas City, Missouri. "In contrast, excessive alcohol intake and binge drinking are toxic to both the heart and overall health and are the third leading cause of premature death among Americans.

The purpose of the present review is to:
1) outline the specific benefits and risks of alcohol, and the threshold of intake at which drinking becomes a health danger rather than an advantage;
2) detail the mechanisms whereby alcohol confers cardioprotection; and
3) discuss the ideal quantities, drinking patterns, and beverages, and which individuals are most likely to benefit."

Research to date has shown J-shaped relationships between alcohol consumption and several adverse health outcomes, including all-cause mortality, CHD, diabetes, hypertension, congestive heart failure, stroke, dementia, and Raynaud's phenomenon.

Some cardioprotective benefits have been demonstrated for light to moderate alcohol consumption (up to 1 drink daily for women and 1 or 2 drinks daily for men). Most studies have shown that light to moderate drinking is associated with risk reductions for CHD of approximately 30% to 35%.

Alcohol consumed in moderation seems to have an antiatherosclerotic effect, with decreased incidence of peripheral arterial disease and decreased atherosclerotic burden shown by coronary angiography, computerized tomography-detected coronary calcium, and carotid ultrasound.
Like exercise, alcohol consumption seems to be most cardioprotective when done daily and in moderation. However, increasingly excessive consumption is associated with proportional worsening of outcomes.

Because of the beneficial effects on high-density lipoprotein (HDL) cholesterol, insulin action, and inflammation, light to moderate alcohol intake may be particularly helpful for patients with abnormal glucose metabolism and/or insulin resistance. Light to moderate alcohol intake may be associated with reductions in the prevalence and incidence of diabetes, and a large meta-analysis with 12-year follow-up showed a 30% reduction in new diabetes in those who consumed 1 to 2 drinks daily.

The cardiovascular benefits associated with alcohol consumption protection are thought to be mediated by improvements in insulin sensitivity and HDL cholesterol. The major protective component seems to be the ethanol itself, and not the other ingredients found in different types of alcoholic beverages.

In a meta-analysis incorporating data from more than 1 million participants, consumption of 1 drink daily by women and 1 or 2 drinks daily by men was associated with an 18% reduction in total mortality, but daily intakes of more than 2 drinks in women and 3 drinks in men were associated with dose-dependent increased mortality.

Although low-dose, daily alcohol consumption has been linked to better health than less frequent use, binge drinking increases cardiovascular events and mortality, even in otherwise light drinkers.

"Alcohol should not be universally prescribed for health enhancement to nondrinking individuals owing to the lack of randomized outcome data and the potential for problem drinking," the study authors note. "Alcohol (ethanol) consumption is analogous to the proverbial double-edged sword, and perhaps no other factor in cardiovascular (CV) health is capable of cutting so deeply in either direction depending on how it is used."

Guidelines from the United Kingdom suggest that middle-aged or elderly men and postmenopausal women who drink seldom or never might consider the possibility that light drinking would benefit their health. On occasion, the reviewers have made a similar recommendation to patients who do not smoke and who have no personal or family history of substance abuse and no history of depression or bipolar disorder. However, they argue that light to moderate drinking should not be universally recommended to the general public or even to patients with cardiovascular disease.

As an analogy, they point out that observational data and findings from randomized trials using surrogate endpoints suggested that hormone replacement therapy for women and antioxidant vitamins improved cardiovascular outcomes, whereas later randomized trials with larger samples led to the opposite conclusions. They note that no randomized trials of alcohol for improving clinical outcomes have yet been performed. In observational studies, residual unmeasured confounding factors could be contributing to apparent benefits that seem to be associated with light to moderate drinking.

The investigators further note that heavy drinking has caused significant individual and societal problems and morbidity. In the past 15 years, the rates of alcohol abuse and binge drinking have been increasing, according to the findings of some studies. Alcohol abuse causes 100,000 deaths each year in the United States, and it has been deemed the third largest preventable cause of death.

Excessive alcohol consumption has been associated with increased risks for all-cause mortality, motor vehicle crashes, stroke, cardiomyopathy, cardiac dysrhythmia, sudden cardiac arrest, suicide, cancer (particularly of the breast and gastrointestinal tract), cirrhosis, fetal alcohol syndrome and sleep apnea.

"Sobering statistics warn that moderate daily drinking is a slippery slope that many individuals cannot safely navigate," the study authors conclude. "The latest American Heart Association guidelines caution people not to start drinking if they do not already drink alcohol, because it is not possible to predict in which people alcohol abuse will become a problem. Until we have more randomized outcome data, and tools for predicting susceptibility to problem drinking, it would seem prudent to encourage physicians and patients to focus on more innocuous interventions to prevent CHD."

J Am Coll Cardiol. Published online August 23, 2007.
2007;50:1009-1014.

Friday, October 20, 2006

Trendy Hormone Treatments No Passage to Graceful Aging

(HealthDay News) -- Forget the fountain of youth, at least for now, and at least in the form of hormone supplements.

Neither DHEA (dehydroepiandrosterone) nor low-dose testosterone replacement had any beneficial effect in elderly people, including quality of life, new research has found.

"I don't find any reason for older people to take DHEA based on this study and no reason to do any extensive studies on it," said study author Dr. K. Sreekumaran Nair, a professor of medicine at the Mayo Clinic in Rochester, Minn. His report is published in the Oct. 19 issue of the New England Journal of Medicine.

Others, however, feel differently.

"This particular study is a small study, and it's only over two years, so I don't think it's the end of the story. We have to wait for more," said Dr. Barbara Paris, vice chairwoman of medicine and director of geriatrics at Maimonides Medical Center in New York City.

That being said, Paris also warned that people need to be careful of taking DHEA, in particular, as it is sold as a dietary supplement without need of a prescription.

"You don't know what you're getting with the pill," she said. "I don't think they're benign even though they're available without a prescription."

Both DHEA and testosterone have become celebrity hormones and are widely touted as anti-aging remedies. Best-selling author Gail Sheehy (Passages) profiled DHEA as a possible anti-aging miracle in Vanity Fair in 1996.

In 2002, however, gerontology experts issued a statement essentially calling supplements such as DHEA a waste of money.

The idea is simple: Because levels of growth hormones decline starting at about age 30, researchers have speculated that hormone replacement would have a slowing effect on aging.

Long-living humans are also known to have relatively high levels of DHEA, but the bulk of research has been done in animals, and it's unclear how the findings might apply to humans.
The new study reports on a two-year-long, randomized, double-blind study involving 87 elderly men with low levels of DHEA and testosterone and 57 elderly women with low levels of DHEA. All participants had to be at least 60 years of age.

The men were randomly assigned to receive DHEA, testosterone or a placebo. The women were randomly assigned to receive either DHEA or a placebo.

Although DHEA and testosterone levels were increased to what would be considered the "high normal" range for young people, there were no appreciable changes in volume of oxygen consumed per minute, muscle strength, sensitivity to insulin or quality of life, the study reported. There were no major adverse effects, either.

Men receiving testosterone had a small increase in fat-free mass, and men receiving either testosterone or DHEA had an increase in bone mineral density at the femoral neck. Women taking DHEA had an increase in bone mineral density at the wrist but nowhere else.

Wrist bone mineral density is probably less important than other locations. "If you break your wrist, it's not the end of the world," Paris said. "The real concern in an 80-year-old is breaking your hip. That can be a death sentence, so even if I take a supplement and I don't get a wrist fracture, that's not really so significant."

Another problem, said Dr. Bernard Roos, director of the geriatric institute at the University of Miami Miller School of Medicine, is that "nobody's ever found that DHEA ever did anything that wasn't a secondary effect of either testosterone or estrogen." But, even here, the results can be highly variable. "It's unpredictable because different people convert DHEA to active hormones differently. It's almost like going to a lottery," Roos added.

In any event, experts called for more of this kind of study on anti-aging products in general.
"There are a lot of people who are buying and selling products under the banner of anti-aging medicine, and prematurely, because they haven't been evaluated in any style," said S. Jay Olshansky, professor of public health at the University of Illinois and senior research scientist at the Center on Aging at the University of Chicago. "It's important that clinical trials be done and that they make these kinds of assessments," he said.

More information
To learn more, visit the U.S. National Institute on Aging.

Saturday, June 24, 2006

Quitting Hormone Replacement Therapy?

Provided by: DrWeil.com

Q: I'm currently on hormone replacement therapy (HRT) and have been for 10 years. I would like to get off. How do I do this? Do I just quit, or do I need to back it down? -- Terri M.

A: Conventional medical wisdom holds that since you've been on HRT for so long, it would be best to wean yourself off slowly. However, the few studies on this subject suggest that it really doesn't matter whether you go cold turkey or withdraw from the hormones gradually: there seems to be no difference in the incidence of menopausal symptoms that develop as a result.

One study, published in the December 2003 issue of Obstetrics and Gynecology, found that about one-quarter of the women participating were unable to discontinue hormone therapy because of the withdrawal symptoms they experienced.

The women who had the most trouble quitting had begun taking estrogen after a hysterectomy, and had been on it for 10 years or more. Of the women in the study who succeeded in withdrawing from HRT, 71 percent quit abruptly and 29 percent tapered off HRT.

There was no difference in the incidence of menopausal symptoms between the two groups. Another study, published in the May, 2004 issue of the Journal of Women's Health, also found no difference in symptoms between women who quit abruptly and those who tapered off. If you decide to wean yourself off HRT, discuss your plan with your doctor. I suggest cutting back on HRT over the course of two months.

You can do this by taking decreasingly lower doses of estrogens. You're probably taking 0.625 mg of estrogen daily. You want to bring this down to 0.4, then 0.3 mgs daily. Either ask your physician to prescribe lower-dose estrogen or start taking your pills every other day, instead of daily. Continue taking your full dose of progestin whenever you take estrogen. If your HRT prescription is for a pill that combines both hormones, ask your physician for separate prescriptions so that you can slowly lower your estrogen dose.

Once you're off the hormones, you may experience hot flashes, night sweats or mood swings, and within two or three months you're likely to notice vaginal dryness and loss of fullness of your breasts. Hormonal changes can also lead to some temporary hair loss. If vaginal dryness becomes problematical, try Replens, a non-hormonal gel, which should be applied three times a week, or use the lubricant Astroglide at the time of intercourse. Both are available over-the-counter. Alternatively, speak to your physician about prescription estrogen creams that can be applied vaginally or the vaginal ring (Estring) that time-releases estradiol (a natural form of estrogen) daily; the ring has to be replaced every 90 days.

If you were taking HRT to protect against osteoporosis, make sure that you're getting 1,500 mg of calcium daily from your diet and, if necessary, from supplements. Weight-bearing exercise, such as brisk walking, along with strength training can protect your bones. If a bone density test shows that you're at high risk of osteoporosis, you may want to consider taking Fosamax (alendronate sodium), Actonel (risedronate sodium) or Evista (raloxifene), prescription medications that can help strengthen bone.

Many women find relief from hot flashes, night sweats and vaginal dryness by taking black cohosh (Cimifiuga racemosa) plus 800 IUs of vitamin E daily. Alternatives include the supplements dong quai and evening primrose oil, which work for some women. Two to three daily servings of whole soy foods (tofu, tempeh, edamame, and soy milk) will give you some safe plant estrogen (phytoestrogens) that may help relieve symptoms. If these natural approaches don't help, talk to your physician about Effexor (venlafaxine) or other drugs that can relieve hot flashes.
Andrew Weil, MD

Friday, February 03, 2006

FIBROCYSTIC BREAST DISEASE

by Tori Hudson, N.D.

Tender or lumpy breasts are one of the most common reasons why women consult their women's health practitioner for assessment and treatment.

Since painful breasts are not always lumpy, and lumpy breasts are not always painful (and neither is usually abnormal), it is useful to create descriptive categories of symptoms and conditions to replace the generic term "fibrocystic."Physiological, Cyclical Pain and SwellingMany women notice painful or sensitive breasts just prior to menstruation.

This has been attributed to a more prominent estrogen than progesterone effect on breast tissue at this time. Occasionally, less progesterone is made late in the cycle, as in irregular ovulation.

Other women may have average amounts of progesterone but increased tissue sensitivity to estrogen with related fluid retention. Most women tolerate this well enough once reassured it is normal, and the symptoms always resolve with menses.

Women who take exogenous estrogen, such as oral contraceptives or estrogen replacement therapy during menopause, may be similarly affected.

Mastalgia Mastalgia refers to any breast pain, unilateral or bilateral, severe enough to interfere with the quality of a woman's life, causing her to seek treatment. Physiologic cyclical mastalgia is this severe about 15 percent of the time, and comprises the bulk of this group.

Women who suffer from noncyclical pain are more rare, and the pain is less likely to be hormonal in cause. Pain may be due to old trauma, acute infection, or sometimes inflammation of the intercostal cartilage, i.e. costochondritis.

In contrast, breast cancer presents as a unilateral painful firm lump about 5 percent of the time. The majority of the time, breast cancer does not present as breast pain, and especially tends not to present as cyclic present pain. Painful swellings that flux with the cycle unchanging over time are not worrisome as cancer signals.

Breast Nodularity or Diffuse LumpinessBreast lumpiness may be either cyclic or non-cyclic, and may be painful. The distinction between these and normal breasts is often simply a matter of degree. Normal breasts are always irregularly textured because the breast tissue is not homogeneous. It is a mix of glands, fat, and connective tissue.

Glands can vary in prominence, and are more or less obscured by fat or fluid, so all breasts feel different on physical exam. Symmetry is important; finding a mirror-image thickening in the opposite breast indicates a normal condition.

Non-Dominant Masses

Densities that are not symmetrical are largely due to benign non-progressive causes, but do require careful distinction from dominant masses.

When palpation of the lump reveals that the density merges in one or more places with the surrounding breast tissue, it is considered "non-dominant" and may be comfortably observed for change over time. When these lesions are biopsied or, preferably, a sample of cells is taken in the office through a needle to be looked at microscopically (fine-needle aspirate), approximately 70 percent will show "non-proliferative changes" (adenosis, fibrosis, microcysts, mild hyperplasia, and more); 20 percent will show "proliferative changes without atypia" -- mostly epithelial hyperplasia. None of these conditions places one at increased risk for cancer, and all are self-limiting.

Only a fraction, roughly the 5 percent that show atypical hyperplasia, carry a significantly increased risk of breast cancer, especially when coupled with a positive family history.

Dominant Masses

Non-cyclical unilateral lesions are clearly distinct on all sides from the surrounding breast tissue.
They persist over time, and except in the very young, demand some kind of assessment. Although rare, breast cancer can occur in women in their twenties. Assessments in younger women are more difficult due to the dense breast tissue therefore rendering mammograms less accurate. And, since most of these unilateral lesions are benign, mammograms and biopsies deserve a more restrained approach, although continued monitoring and revisiting clinical decisions are very important.

Most commonly dominant masses are either fibroadenomas or gross cysts. A fibroadenoma is a rubbery, smooth, benign, fibrous tumor common in younger women. In women under age 25, it can be observed over time. They generally do not grow bigger. Large cysts are more common in women aged 25 to 50 -- an age group when cancer just begins to appear.

They are softer, squishier, and can be made to disappear by draining them through a needle in the office. Unless they recur frequently, no further treatment is necessary. Recurrent large cysts have been shown to slightly increase cancer risk in some studies but not in others; fibroadenomas do not. Unfortunately, non-cyclical unilateral dominant masses can sometimes be cancerous.

Overview of Alternative Treatments for Cyclic Breast Pain and Swelling

Alternative medicine principles for fibrocystic breast tissue or cyclical pain and swelling include the recognition that the liver is the primary site for estrogen clearance or estrogen metabolism. A compromised liver function can lead to a state of estrogen dominance, contributing to texture and density changes in the breast.

To assure that estrogens are being metabolized properly, it may be necessary to provide nutritional and herbal support for the liver.Digestion and elimination are also fundamental factors involved in a more holistic approach to hormone-related health problems.

Women having fewer than three bowel movements per week have a risk of fibrocystic breasts four to five times greater than women having at least one bowel movement per day. The longer it takes food to move through the colon, the more waste products can be reabsorbed into the bloodstream, creating a potentially toxic physiological environment.

Bacterial flora in the large intestine, such as Lactobacillus acidophilus, improves the transit time of bowel toxins, as well as improving the excretion and detoxification of estrogens.

NutritionRemoval of caffeine from the diet is probably the most well-known alternative lifestyle approach for fibrocystic breasts. The first randomized study of a large number of women was conducted by Dr. Virginia Ernster.

One hundred fifty-eight women eliminated all caffeine (coffee, tea, cola, chocolate, and caffeinated medications) from their diets for four months.1 There was a significant reduction in clinically palpable breast findings in the abstaining group compared with the control group, although the absolute change in the breast lumps was quite minor and considered to be of little clinical significance. Several other studies provided mixed reports: three studies show no association between methylxanthines and benign breast disease,2,3,4 and two studies show a correlation with caffeine consumption.5,6
Caffeine content of common items

Beverage
Serving Size
Caffeine (mg)
Coffee, drip
5 oz
110-150
Coffee, perk
5 oz
60-125
Coffee, instant
5 oz
40-105
Doffee, decaffeinated
5 oz
2-5
Tea, 5 minutes steep
5 oz
40-100
Tea, 3 minutes steep
5 oz
20-50
Hot cocoa
5 oz
2-10
Coca-Cola
12 oz
45
Food
Serving Size
Caffeine (mg)
Milk chocolate
1 oz
1-15
Bittersweet chocolate
1 oz
5-35
Chocolate cake
1 slice
20-30
OTC Drugs
Dose
Caffeine (mg)
Anacin, Emprin
2
64
Excedrin
2
130
NoDoz
2
200
Aqua-Ban
2
200
Dexatrim
1
200
How dietary fat affects the human breast is confusing and controversial. Reducing the fat content of the diet to 15 percent of total calories, while increasing complex carbohydrate consumption, has been shown to reduce the severity as well as the actual breast swelling and nodularity in some women.

Reducing the dietary fat intake to 20 percent of total calories also results in significant decreases in circulating estradiol. Since fibrocystic breasts are a result of estrogen dominance, it is logical that decreasing estrogens in the body would improve the symptoms of breast pain and swelling.

However, only a slight reduction in fat intake has repeatedly shown very little, if any, effect on breast problems, including breast cancer. A more rigorous approach to lowering the amount of fat in the diet is clearly needed. Of note, women on a vegetarian diet excrete two to three times more detoxified estrogens than women on an omnivorous diet.Nutritional SupplementsVitamin EFor more than 35 years, clinicians have used vitamin E in the medical management of benign breast disease.

This practice was initially based on positive reports from small numbers of patients as far back as 1965, and in subsequent studies in 1971, 1978, and 1982. When larger numbers of women were studied, vitamin E did not show significant effects. However, two studies demonstrated that vitamin E is clinically useful in relieving pain and tenderness, whether cyclical or non-cyclical.7,8 The studies have been done with varying dosages: 150, 300, or 600 IU daily.

In clinical practice, practitioners generally recommend from 400-800 IU of D-alpha-tocopherol with a minimum trial period of two months.Evening Primrose OilThe pain and tenderness of benign breast disease associated with "cyclic mastalgia" have been alleviated with evening primrose oil, the only one of the fatty acids to be scientifically studied in relation to fibrocystic breasts. In a study of 291 women who took three grams per day of evening primrose oil for three to six months, almost half of the 92 women with cyclic breast pain experienced improvement, compared with one-fifth of the patients who received the placebo.

For those women who experienced breast pain throughout the month, 27 percent responded positively to the evening primrose oil, compared to 9 percent on the placebo.9 Another study of 73 women received three grams per day of evening primrose oil or placebo.

After three months, pain and tenderness were significantly reduced in both cyclical and non-cyclical groups, while the women who took placebo did not significantly improve. IodineThyroid hormone with low or even normal thyroid function may result in improvement of fibrocystic breasts.

These results suggest that iodine deficiency may be a factor in fibrocystic breasts. Breast tissue has an affinity for both thyroid hormone and iodine. Without iodine, it becomes more sensitive to estrogenic stimulation, which in turn produces microcysts high in potassium content. The potassium is believed to be an irritant that produces fibrosis and eventually cyst isolation.

Four types of iodine have been studied in the treatment of fibrocystic breasts, only one of which has been truly effective for both pain reduction and cyst reduction, and free of side-effects on the thyroid gland. All forms of iodine relieve subjective clinical symptoms: sodium iodide (Lugol's solution); potassium iodide; caseinated iodine (protein-bound); and aqueous (diatomic) iodine.

Symptom relief varied a great deal with the different iodines, but only the aqueous or diatomic iodine achieved both symptom relief in 74 percent of the women, as well as objective reduction in nodules and resolution of fibrosis in 65 percent of the patients, without adverse effects on the thyroid gland.10 The recommended dose of aqueous iodine is a prescription of 3-6 mg per day.

Other

Supplements that may improve liver function and thereby perhaps promote a more balanced estrogen metabolism include methionine and choline. B vitamins, particularly vitamin B-6, can help the liver to properly metabolize and conjugate estrogens. Probiotics such as Lactobacillus acidophilus may be able to improve the absorption and transport of estrogen by supporting a normalized intestinal microflora environment.

Botanicals

Herbal therapies for addressing the symptoms of breast pain, swelling, and cystic nodules in breast tissue are largely arrived at from traditional uses of herbal medicines and from observational empirical evidence in clinical practice.

Herbal diuretics can be useful in decreasing breast swelling and the discomfort associated with it.

The most effective of these is dandelion leaf, but other diuretics to consider are cleavers, yarrow, and uva ursi. Poke root has been used in traditional naturopathic medical practices for decades. It can be applied topically as an oil to the breasts, reducing painful lumpiness and nodularity.

Herbal support for the liver improves how the liver metabolizes steroid hormones. Traditional herbs that support the liver and the normalization of biochemical steroid pathways may include burdock root, dandelion root, and milk thistle.

Natural Progesterone

Assuming fibrocystic breasts are at least in part due to a high-estrogen, low-progesterone ratio, then it is logical to use progesterone therapy as a treatment. Many practitioners and women have experienced that the application of natural progesterone in a cream or gel routinely solves the problem. It may be that progesterone is desensitizing the breast to estrogen. General use guidelines are tsp twice per day, on days 15 to 27 of the monthly cycle.

Summary

These simple therapies, along with lifestyle modification, generally yield very satisfying results within 1 to 3 months, even in women with significantly painful breasts. Although uncommon, if there is no change after three menstrual cycles, a more aggressive alternative treatment plan must be initiated.

If this does not bring relief, then the conventional medical approaches, to be contemplated in very difficult, unbearable cases with no response from natural therapies, include decreasing hyperinsulinemia, synthetic progestin, Danazol, Tamoxifen and bromocriptene. Many women's medicine healthcare providers agree that the term fibrocystic breast "disease" or "condition" should be abandoned in favor of a more accurate physiologically based description. Benign breast conditions are present in almost all women to some degree.

Moreover, the widespread misconception that women with painful or lumpy breasts are at increased risk of breast cancer is inaccurate. This reinforces misinformation and fear, and obscures the safe and simple means that exist for obtaining relief and reassurance.

References1 Ernster V, Mason L, Goodson W, et al. Effects of caffeine-free diet on benign breast disease: a randomized trial. Surg 1982;912:263-267.2 Lubin F, et al. A case-control study of caffeine and methylxanthine in benign breast disease. JAMA 1985; 253(16)2388-92.3 Shawer C, Brinton L, Hoover R. Methylxanthine and benign breast disease. Am J Epid 1986;124(4): 603-11.4 Marshall J, Graham S, Swanson M. Caffeine consumption and benign breast disease: a case-control comparison. Amer J Pub Health 1982;72(6):610-12.5 La Vecchia C, et al. Benign breast disease and consumption of beverages containing methylxanthines. JNCI 1985;74(5):995-1000.6 Boyle C, et al. Caffeine consumption and fibrocystic breast disease: a case-control epidemiologic study. JNCI 1984;72(5):1015-19.7 London R, et al. Mammary dysplasia: Endocrine parameters and tocopherol therapy. Nutr Res 1982;7:243.8 London R, et al. Endocrine parameters and alpha-tocopherol therapy of patients with mammary dysplasia. Canc Res 1981;41:3811-13.9 Pye J et al. Clinical experience of drug treatment for mastalgia. Lancet 1985;2:373-77.10 Ghent W, et al. Iodine replacement in fibrocystic disease of the breast. Can J Surg 1993. Oct; 35(5):453-60.

more info at: www.dreddyclinic.com/ and http://www.dreddy-clinic.com/


more discussion: Forum
· Addiction Forum · Ask the Doctors Forum · Ayurveda Forum · Ayurvedic & Thai Herbs Forum · Colon Cleansing Forum · Dental Forum · Diabetes Forum · Diet Forum · General Cleansing Forum · Hepatitis A, B. C Forum · Integrated Medicine Forum · Live Blood Analysis Forum · Ozone-Oxygen-Forum · pH - Alkaline - Acidity Forum · Weight Loss Forum

ClickComments

Balancing Your Hormones Without Drugs... You Can Feel Good Again

Balancing Your Hormones Without Drugs... You Can Feel Good Again

$19.95
[ learn more ]

Add to Cart

Hormone imbalance can be reversed! Look and feel better than ever, just take the time to learn about yourself and read the information contained in this just released e-book about reversing hormone imbalance. Are you ready to finally look and feel great? If so... read on... - E-Book Version.(BH)